DYRK1B and hepatocellular carcinoma: Here, we show that pharmacological inhibition or genetic depletion of DYRK1B, but not GSK3β, reversed cyclin D1 turnover induced by BafA1 in HCC cells, suggesting a critical role of DYRK1B in BafA1-induced cell cycle arrest.